{"id":"W2120775216","doi":"10.1158/1078-0432.ccr-05-0577","title":"Immunomodulatory Drug CC-5013 or CC-4047 and Rituximab Enhance Antitumor Activity in a Severe Combined Immunodeficient Mouse Lymphoma Model","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Pharmacology; In vivo; Immunology; Thalidomide; Cytokine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002406507,0.0005346658,0.0004657411,0.000564403,0.0001034312,0.0002953435,0.0003456751,0.0003879986,0.001100409],"category_scores_gemma":[0.00008533999,0.000212635,0.0002917414,0.0002116128,0.0002308956,0.000298672,0.0001424062,0.0008289061,0.0002690951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003062627,"about_ca_system_score_gemma":0.0002148122,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008026834,"about_ca_topic_score_gemma":0.001269605,"domain_scores_codex":[0.9997231,0.0000512173,0.00002560595,0.0000417324,0.00008433345,0.0000738971],"domain_scores_gemma":[0.9998581,0.00001893513,0.0000453203,0.00001251636,0.00001126873,0.0000537767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000546018,0.0003244737,0.0001943686,0.00003331899,0.00001088888,0.00005685696,0.00001764369,0.0001637934,0.9965329,0.00009273694,0.00007932468,0.001947716],"study_design_scores_gemma":[0.0001515995,0.00628756,0.003442681,0.00001112582,0.00005989261,0.0003354304,0.0000285121,0.002559993,0.9851251,0.00004244168,0.001948432,0.000007172922],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959248,0.00113469,0.001015625,0.00008572202,0.00002281733,0.00004380399,0.000204669,0.0000922979,0.001475587],"genre_scores_gemma":[0.9950556,0.0008363131,0.001235598,0.00004546906,0.00001649867,0.00006512427,0.0003378627,0.00001016451,0.002397375],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001100409,"threshold_uncertainty_score":0.003681302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1365087731726329,"score_gpt":0.4895919098064508,"score_spread":0.353083136633818,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}